Skip to content
Screener

Solventum SOLV Purification and Filtration Segment — Total Net Sales

Other segment segments

MedSurg
$1.37B+12.6%
Dental Solutions
$396M+17.2%
Health Information Systems
$354M+4.4%

Similar metrics at other companies

Bioventus logo
BVSInternational Segment — Total Net Sales
$18.74M-0.8%
Bioventus logo
BVSU.S. Segment — Total Net Sales
$134.47M+4.4%
VGN
VGNTReportable Segment — Total Net Sales
$2.21B+9.3%
Wabtec logo
WABFreight Segment — Total Net Sales
$2.24B+16.9%
Wabtec logo
WABTransit Segment — Total Net Sales
$936M+18.9%
Primo Brands logo
PRMBReportable Segment — Total Net Sales
$1.8B+3.8%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
Net Sales (Millions)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Dental Solutions396338750667
Health Information Systems354339696667
Total reportable segment net sales2,1221,8954,0533,709
Purification and Filtration189369
All Other8777163153
Total net sales$2,209$2,161$4,216$4,231
Three months ended June 30,Six months ended June 30,
Cost of Sales (Millions)2026202520262025

Item 1. Financial Statements

FAQ

What is Solventum's purification and filtration segment — total net sales?
Solventum (SOLV) reported purification and filtration segment — total net sales of $0 in Q2 2026.
How has Solventum's purification and filtration segment — total net sales changed year-over-year?
Solventum's purification and filtration segment — total net sales decreased by 100.0% year-over-year, from $189M to $0.
What is the long-term trend for Solventum's purification and filtration segment — total net sales?
Over 3 years (2022 to 2025), Solventum's purification and filtration segment — total net sales has grown at a -20.5% compound annual growth rate (CAGR), from $991M to $497M.
What does purification and filtration segment — total net sales mean?
This metric represents the total revenue generated from the sale of products and services within the purification and filtration business unit. It reflects the market demand for specialized separation technologies used in healthcare and industrial applications. Tracking this figure helps investors assess the growth trajectory and market penetration of the company's core filtration solutions.

Ask your AI about Solventum's purification and filtration segment — total net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude